beth israel deaconess medical center a harvard medical school teaching hospital

  • Contact BIDMC
  • Maps & Directions
  • Other Locations
  • Careers at BIDMC
  • Smaller Larger

Find a Doctor

Request an Appointment

Smaller Larger


Posted 12/5/2016

Posted in

  Before I move along to today's tantalizing topic, I want to share the fact that today, December 5th, is my birthday. Growing up, birthdays were always gently celebrated in my family--that is, there were a few gifts and dinner of choice and a cake, but not a blow out celebration. That approach has continued to feel comfortable to me, and, all these years post my first cancer in 1993, I have been increasingly grateful and committed to having a normal day. Remember Emily in Our Town?  All she wanted was to return to life for one regular old day.

  We are having our first snow of the season, and it was coming down pretty hard around 7 AM when I normally depart for work. I made a self-serving decision to slow down, had a real breakfast of soft-boiled eggs and an English muffin, and watched the birds at our feeders. By the time I left home, the traffic was greatly reduced, and the drive was easy. And I am feeling relaxed.

  One absolute positive, probably the only one, of having had cancer for me is my delight in growing old. Hurrah for each year and each gray hair and each wrinkle? I never thought I would live to 50, so all these years are a bonus and a blessing.

  And here is about mushrooms to brighten your day:

For Cancer Distress, Hallucinogen Has Unprecedented Results
Nick Mulcahy

Treatment with psilocybin, the active compound in hallucinogenic "magic mushrooms," results in fast and long-lasting relief from anxiety and depression among a majority of patients with cancer, including advanced disease, according to two similarly designed studies published online December 1 in the Journal of Psychopharmacology.

The reported efficacy is "unprecedented in psychiatry and psycho-oncology," said Roland Griffiths, PhD, a neuroscientist and the lead investigator of a 51-patient study at the Johns Hopkins University in Baltimore, Maryland. When the study patients received a single high dose of synthetic psilocybin, the overall rate of clinical response at 6 months for the primary outcomes of depression and anxiety was 78% and 83%, respectively, and the overall rate of complete symptom remission was 65% and 57%.
"Psilocybin may represent a potential paradigm shift for treating patients suffering from cancer-related psychological distress," added Dr Griffiths, who spoke at a presscast for journalists.

Read more:


Add your comment